LS mean differences in change in ADPS from baseline to week @ versus placebo were -@ , -@ , -@ , -@ , and -@ for the mirogabalin @ - , @ - , @ - , @ - , and @-mg/day treatment groups , respectively , and -@ in the pregabalin group ( P < @ versus placebo for mirogabalin @ , @ , and @ mg/day ) .